PC Deedwania, R Gupta - JOURNAL-ASSOCIATION OF PHYSICIANS OF INDIA, 2006 - japi.org Multifaceted etiology of cardiovascular diseases,especially coronary heart
disease, has beenrecognized for a long time1 and clustering of
multiplecardiovascular risk factors has been known for at least80 years. ... Cited by 13 - Related articles - Cached - BL Direct - All 6 versions
WE Hoy - Kidney international, 2006 - nature.com Only recently has the nephrology community moved beyond a fairly singular focus
on terminal kidney failure to embrace population-based studies of earlier stages
of disease, its markers and risk factors, and of interventions. ... Cited by 6 - Related articles - BL Direct - All 4 versions
K Rockwood, S Howlett, J Fisk, S Darvesh, H … - Neuroepidemiology, 2007 - content.karger.com Page 1. Fax +41 61 306 12 34 E-Mail karger@karger.ch www.karger.com Original
Paper Neuroepidemiology 2007;29:201–207 DOI: 10.1159/000111583 ... Cited by 6 - Related articles - BL Direct - All 4 versions
MJ Jamieson, M Naghavi - Current pharmaceutical design, 2007 - ingentaconnect.com 1 Clinical Associate Professor of Medicine and Pharmacology, University of Texas
Health Science Center, San Antonio, Texas and Scientific Advisor to the
Association for Eradication of Heart Attack (AEHA) and Cited by 4 - Related articles - BL Direct - All 4 versions
M Diamant, ME Tushuizen, MNA Hussein, CM … - Endothelial cell-derived microparticles - dare.uva.nl Simvastatin-induced endothelial detachment 98 ABSTRACT Background: Statins
reduce cardiovascular disease risk and affect endothelial function by
cholesterol-dependent and independent mechanisms. Recently, circulating ( ... Cited by 5 - Related articles - View as HTML - All 5 versions
GA Diamond, S Kaul - Circulation: Cardiovascular Quality and Outcomes, 2009 - Am Heart Assoc Incremental or marginal cost-effectiveness ratios are founded on a number of
assumptions that weaken their suitability as a way to balance competing economic
and clinical priorities. We therefore propose a more relevant and ... Cited by 2 - Related articles
V Kumar, B Prasad, S Singh - Drug Discovery Today: Therapeutic Strategies, 2008 - Elsevier Cardiovascular diseases (CVDs) are the foremost cause of mortality worldwide. It
is estimated that around 20 million people will die from CVDs by 2015.
Accordingly, there is a need to develop treatment strategies, which on ... Cited by 2 - Related articles
[CITATION] Polypharmacotherapy for primary prevention of cardiovascular disease
CE Ezenwaka, E Nwagbara, D Seales, F Okali, … - International Journal of Cardiology, 2009 - Elsevier Three hundred and twenty-five (106 males, 219 females) type 2 diabetic patients
resident in two Caribbean Islands of Tobago and Trinidad met the UKPDS risk
engine inclusion criteria. Records of their sex, age, ethnicity, smoking ... Cited by 1 - Related articles - All 32 versions
AO Stirban, D Tschoepe - Diabetes Care, 2008 - Am Diabetes Assoc The reality of primary and secondary prevention of cardiovascular complications
in people with diabetes is alarming, even in developed countries with a
well-structured medical system. Even though therapeutic targets have been ... Cited by 1 - Related articles - BL Direct - All 5 versions
